Takeda Pharmaceuticals USA, Inc. data breach

Clerk's notes

Takeda Pharmaceuticals USA, Inc., a global biopharmaceutical company, filed a report with the Texas Attorney General regarding a data breach on June 26, 2026. This disclosure indicates that a security incident has occurred, impacting individuals whose information Takeda holds.

While the specific categories of data involved in this breach were not detailed in the public filing, Takeda's notification letters to affected individuals clarify what personal information may have been exposed. Recipients of these letters should understand that their data was potentially compromised in the incident.

The breach itself was identified as occurring on February 9, 2026, with the official filing following several months later. The status of this incident is currently listed as "investigating," meaning authorities are still reviewing the circumstances and full impact of the breach.

If you have received an official data breach notification letter from Takeda Pharmaceuticals USA, Inc., it is crucial to read it thoroughly. This document provides specific details about the incident, the information involved, and any identity protection services or steps recommended by the company.

It is generally advisable to remain vigilant for any unusual activity in your accounts and to monitor your credit reports. Activating any offered identity monitoring services can also help detect potential misuse of your personal information. Be cautious of unsolicited communications that claim to be from Takeda, especially those asking for personal details.

For those affected by this Takeda Pharmaceuticals USA, Inc. data breach, understanding your rights and options is important. If you are concerned about how this incident might impact you, a free case review can help clarify potential next steps without any obligation.

If a notification letter about this breach reached you, see every Texas data breach on file or browse all cases.